Randomized, Multicentric Phase IV Clinical Trial for the Administration of Pamidronate in Breast Cancer Patients With Bone Metastases
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Pamidronate efficacy to prevent first skeletal event
Agustí Barnadas, MD., PhD.
Hospital Santa Creu i Sant Pau
Spain: Spanish Agency of Medicines